Lantern Pharma LTRN Q1 2026 Earnings EPS Beats Estimates by 183 Despite Absence of Revenue WASH Q1 2026 Earnings EPS Misses Estimates Stock Slips 074 UTI Q1 2026 Earnings EPS Misses Estimates but Stock Climbs on Positive Indicators EDRY Q1 2026 Earnings Significant EPS Miss Amid Challenging Dry Bulk Market FLNA Q3 2025 Earnings NarrowerThanExpected Loss Drives Stock Rally AEON Biopharma Q4 2025 Earnings Major EPS Miss and No Revenue Weigh on Investor Sentiment